據以色列廣播公司：一位以色列官員表示，特朗普處理事務的方式使得認真準備和規劃未來變得困難。

伊朗外交部發言人：霍爾木茲海峽未來的管理工作，將由伊朗與阿曼協商進行。

Financial Times: AstraZeneca is exploring a merger with U.S. peer Bristol Myers Squibb that would create one of the world’s largest drugmakers with a combined market value near $400 bln. The companies have held talks in recent months and could reach an agreement soon, but negotiations may also be delayed or collapse. AstraZeneca’s market cap is about £196 bln; Bristol Myers Squibb’s is about $133 bln. The transaction would further accelerate AstraZeneca’s strategic shift toward the U.S. market.